Vascular and Neural Dysfunctions in Obese Zucker Rats: Effect of AVE7688

Davidson, Eric P.; Coppey, Lawrence J.; Kleinschmidt, Travis L.; Oltman, Christine L.; Yorek, Mark A.
January 2009
Experimental Diabetes Research;2009, Special section p1
Academic Journal
The purpose of this study was to determine whether AVE7688 a drug that inhibits both angiotensin converting enzyme and neutral endopeptidase activity protects vascular and nerve functions in an animal model of metabolic syndrome. Obese Zucker rats at 20 weeks of age were treated for 12 weeks with AVE7688. Vasodilation in epineurial arterioles was measured by videomicroscopy and nerve conduction velocity was measured following electrical stimulation. Treatment with AVE7688 improved vascular relaxation in response to acetylcholine and motor and sensory nerve conduction velocity. In obese Zucker rats superoxide levels and nitrotyrosine staining were elevated in the aorta and treatment corrected both conditions. Obese Zucker rats were hypoalgesic in response to a thermal stimulus and demonstrated signs of impaired tactile response and both conditions were significantly improved with treatment. Even though obese Zucker rats are normoglycemic vascular and neural dysfunctions develop with age and can be improved by treatment with AVE7688.


Related Articles

  • vasopeptidase inhibitor.  // Taber's Cyclopedic Medical Dictionary (2009);2009, Issue 21, p2442 

    A definition of the term "vasopeptidase inhibitor," which refers to any member of a class of medications blocking the actions of both angiotensin converting enzymes (ACE) and neural endopeptidase, is presented.

  • The renin, angiotensin, aldosterone, and obesity connection. Luft, Friedrich // Journal of Molecular Medicine;Sep2010, Vol. 88 Issue 9, p861 

    The article discusses the implication of leptin and angiotensin (Ang) II in the pathogenesis of obesity, hypertension and the metabolic syndrome. Researcher A. M. Hilzendeger and colleagues studied the leptin-deficient ob/ob mouse and found that it promotes the synthesis of...

  • The Zinc Metallopeptidase Family: New Faces, New Functions. Lew, Rebecca A. // Protein & Peptide Letters;Oct2004, Vol. 11 Issue 5, p407 

    The abstract for this article is not available.

  • Enkephalin Degrading Enzymes: Metalloproteases with High Potential for Drug Development. Khaket, Tejinder Pal; Singh, Jasbir; Attri, Pooja; Dhanda, Suman // Current Pharmaceutical Design;1/11/2012, Vol. 18 Issue 2, p220 

    Enkephalins play a great role in management of pain, blood pressure, hypertension and cardiovascular diseases. Enkephalins are short-lived molecules being rapidly hydrolyzed following their synaptic release by enkephalin degrading enzymes. The inhibitors of enkephalin degrading enzymes are able...

  • Inhibitors of endopeptidase and angiotensin-converting enzyme lead to an amplification of the morphological changes and an upregulation of the substance P system in a muscle overuse model. Yafeng Song; Stål, Per S.; Ji-Guo Yu; Lorentzon, Ronny; Backman, Clas; Forsgren, Sture // BMC Musculoskeletal Disorders;2014, Vol. 15 Issue 1, p1 

    Background We have previously observed, in studies on an experimental overuse model, that the tachykinin system may be involved in the processes of muscle inflammation (myositis) and other muscle tissue alterations. To further evaluate the significance of tachykinins in these processes, we have...

  • Tubular urinary enzymes in acute post-infectious glomerulonephritis. Naghettini, Alessandra Vitorino; Koch Nogueira, Paulo Cesar; Juliano, Maria; Bueno, Allain Amador; Casarini, Dulce Elena; de Abreu Carvalhaes, João Tomás // Pediatric Nephrology;Sep2001, Vol. 16 Issue 9, p719 

    Tubular function of 17 pediatric patients with a mild form of acute post-infectious glomerulonephritis was prospectively evaluated by assessment of the urinary activity of proximal and distal tubule enzymes. Neutral-like endopeptidase (NEP-like) and angiotensin-converting enzyme (ACE) were the...

  • Human renal angiotensin I converting enzyme and neutral endopeptidase. Skidgel, Randal A.; Schulz, Werner W.; Lei-Ting Tam; Erdö, Ervin G. // Kidney International Supplement;May1987, Issue 20, p45 

    Discusses human renal angiotensin I converting enzyme (ACE) and neutral endopeptidase (NEP). Detection of renal angiotensin I converting enzyme or kininase II (ACE EC) in a microsomal fraction of the hog kidney and its purification from hog, bovine, and human kidney; Hydrolysis of substrates by...

  • Renal metabolism of angiotensin I and II. Ervin G. Erdös; Skidgel, Randal A. // Kidney International Supplement;Nov1990, Issue 30, pS-24 

    The enzymatic hydrolysis of angiotensin I and II is reviewed briefly with emphasis on two enzymes, the angiotensin I converting enzyme and neutral endopeptidase 24.11. Angiotensin I is converted to angiotensin II by converting enzyme present in many tissues and highly concentrated in the human...

  • Role of renal endopeptidase 24.11 in kinin metabolism in vitro and in vivo. Ura, Nobuyuki; Carretero, Oscar A.; Erdos, Ervin G. // Kidney International;Oct1987, Vol. 32 Issue 4, p507 

    The relative contributions of three kininases to total urinary kininase activity were determined by measuring the hydrolysis of kinins in the presence and absence of inhibitors of kininase I (2-mercaptomethyl-3-guanidinoethylthiopropanoic acid; MGTA), kininase II (captopril) and neutral...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics